作者:Ivie L. Conlon、Daniel Van Eker、Sameh Abdelmalak、William A. Murphy、Hassan Bashir、Michael Sun、Jay Chauhan、Kristen M. Varney、Raquel Godoy-Ruiz、Paul T. Wilder、Steven Fletcher
DOI:10.1016/j.bmcl.2018.03.050
日期:2018.6
Accordingly, the development of Mcl-1 inhibitors largely focuses on synthetic BH3 mimicry. The condensation of α-pyridinium methyl ketone salts and α,β-unsaturated carbonyl compounds in the presence of a source of ammonia, or the Kröhnke pyridine synthesis, is a simple approach to afford highly functionalized pyridines. We adapted this chemistry to rapidly generate low-micromolar inhibitors of Mcl-1 wherein
通过结合相对的Bcl-2家族成员的BH3α-螺旋死亡结构域,中和它们并防止细胞凋亡,来表达上调的Mcl-1的致瘤活性。因此,Mcl-1抑制剂的开发主要集中在合成的BH3模拟物上。在氨源或α-β-不饱和羰基化合物的缩合下,在氨源或Kröhnke吡啶的合成下,这是提供高度官能化吡啶的简单方法。我们采用了这种化学方法以快速生成Mcl-1的低微摩尔抑制剂,其中2,4,6-取代基预计可模仿 BH3α-螺旋的i,i + 2和i + 7侧链。